Title of article
Sofosbuvir and Ribavirin to Treat Hepatitis C Virus Genotype 4 Infection in a 65-Year-Old Patient With Diabetes and Low Platelet: A Case Report
Author/Authors
Hussein، Nawfal R نويسنده Department of Internal Medicine, College of Medicine, University of Duhok, Duhok, Kurdistan Region, Iraq ,
Issue Information
فصلنامه با شماره پیاپی 0 سال 2016
Pages
2
From page
1
To page
2
Abstract
Hepatitis C virus (HCV) is a major public health problem especially in the elderly. The classical interferon/ribavirin regimen was unfavorable for elderly patents due to intolerability and adverse effects. More studies are needed about the safety profile of new direct-acting antiviral (DAA) in the elderly. Here, a case of chronic HCV was described in a 65-year-old female with diabetes and low platelet count. The patient was treated successfully by a combination of sofosbuvir+ ribavirin without major side effects. This report highlighted the importance and the safety of this regimen to treat HCV in the elderly.
Journal title
International Journal of Infection
Serial Year
2016
Journal title
International Journal of Infection
Record number
2399608
Link To Document